Condition
Advanced Cancers
Estimated Enrollment: 142
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 2014-0640|NCI-2015-00693
Study First Received: April 14, 2015
Last Updated: March 10, 2017
Estimated Primary Completion Date: June 2019
Primary Outcome Measures:
Maximum Tolerated Dose (MTD)|Disease Control
Sponsors and Collaborators:
M.D. Anderson Cancer Center|Karyopharm Therapeutics Inc
Website Link: https://ClinicalTrials.gov/show/NCT02419495
